Mark Sheptoff Financial Planning, LLC Exelixis, Inc. Transaction History
Mark Sheptoff Financial Planning, LLC
- $177 Million
- Q1 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 300 shares of EXEL stock, worth $11,952. This represents 0.01% of its overall portfolio holdings.
Number of Shares
300Holding current value
$11,952% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding EXEL
# of Institutions
603Shares Held
255MCall Options Held
1.38MPut Options Held
962K-
Black Rock Inc. New York, NY33.5MShares$1.33 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$898 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$591 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$470 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...